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A workshop “Ultra-High Field MRI: 
Transition to Human 7 T in Finland” was 
organized at Aalto University on October 
8–9, 2015. The organizers included Aalto 
University School of Science, Finnish 
Infrastructures for Functional Imaging 
(FIFI), Aalto NeuroImaging (ANI), Aalto 
Brain Centre (ABC), and Department of 
Neuroscience and Biomedical Engineering 
(NBE). The purpose of the workshop was to 
demonstrate scientiﬁc achievements and 
possibilities enabled by ultra-high ﬁeld 
(UHF) magnetic resonance imaging (MRI). 
The meeting brought together a group of 
top-level scientists for two days to give 
presentations and immerse in discussions. 
This memorandum not only documents the 
meeting but also paves the way for making 
the ﬁrst human 7 T scanner operational in 
Finland in the near future. 
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• Kamil	Ugurbil,	Center	for	Magnetic	Resonance	Research,	University	of	Minnesota,	Minneapolis,	MN,	USA		In	 addition	 to	 the	 scientific	 speakers’	 sessions,	we	 organized	 a	manufacturers’	session,	 where	 we	 heard	 from	 three	 major	 UHF	 MRI	 system	 vendors.	 Their	representatives	were:	
• Mark	Symms,	GE	Healthcare	
• Karin	Markenroth	Bloch,	Philips	Healthcare	
• Christina	Triantafyllou,	Siemens	Healthcare		The	workshop	attracted	more	than	120	participants	(speakers	included).	Out	of	the	 110	 who	 had	 pre-registered	 and	 answered	 to	 the	 question	 about	 their	primary	interest	in	the	workshop,	75%	identified	themselves	as	potential	users	(basic	 research,	 clinical	 research,	 diagnostic)	 of	 a	 7	 T	 facility,	 fewer	 than	 5%	were	 from	 research	 administration	 and	 one	 fifth	 attended	 the	 symposium	 for	other	 purposes.	 To	 the	 question	 regarding	whether	 the	 participant	 or	 his/her	group	would	 be	willing	 to	 use	 a	 7	 T	 scanner	 installed	 in	 Otaniemi,	 Espoo,	we	received	44	replies,	out	of	which	the	vast	majority	(more	than	90%)	was	either	‘yes’	or	‘maybe’	(see,	Figure	1).		Participants,	 excluding	 the	 invited	speakers,	 arrived	 from	13	different	national	institutions/hospitals	 and	 2	 institutions	 from	 abroad	 (Marmara	 University,	
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MEG	scan	right	after	a	7	T	scan?	Electromagnetic	 and	 hemodynamic	 imaging	 detect	 fundamentally	 different	types	of	signals,	thus	offering	complementary	windows	to	brain	function.	Above	and	 beyond	 their	 differential	 emphasis	 on	 high	 temporal	 resolution	(electromagnetic	recordings)	and	spatial	resolution	(hemodynamic	recordings),	their	 inherent	 characteristics	 may	 also	 highlight	 different	 types	 of	 neural	processing	 (e.g.,	 bottom-up	 vs.	 top-down	 processing).	 These	 are	 fundamental	research	 questions	 that	 can	 open	 up	 important	 future	 possibilities	 for	neuroscience.	 The	 high	 spatial	 resolution	 of	 7	 T	 fMRI	 that	 allows	 to	 far	more	reliably	 focus	 on	 actual	 neural	 activity	 (and	 less	 on	 the	 veins)	 is	 pivotal	 to	 a	deeply	 informative	 combined	 use	 of	 electromagnetic	 and	 hemodynamic	 brain	imaging.		MEG	recordings	immediately	after	an	MRI	scan	(whether	1.5	T,	3	T	or	7	T)	can	be	problematic	if	the	individual	has	magnetic	material	on	his/her	body	(e.g.,	in	hair	color,	 permanent	 eye	 liner	 etc.).	 Such	 magnetization	 may	 not	 interfere	noticeably	with	the	MRI	scan	but	may	appear	as	intolerable	magnetic	artifacts	in	the	extremely	sensitive	MEG	recordings.	The	magnetization	dissolves	over	time.	
Status	of	clinical	scans	at	7	T?	Currently	 3	 T	 is	 the	 gold	 standard	 in	 clinical	 imaging	 and	 diagnostics.	 The	achievements	and	progress	made	with	7	T	are	 thus	compared	with	 the	results	obtained	 using	 a	 3	 T	 device.	 Many	 clinical	 applications,	 such	 as	 fMRI,	susceptibility	 weighted	 imaging	 (SWI),	 multinuclear	 MRI	 and	 magnetic	resonance	 spectroscopy	 (MRS),	 are	 being	 used	 at	 3	 T	 but	 they	 suffer	 from	limited	 sensitivity.	 7	 T	 will	 greatly	 expedite	 their	 usefulness	 for	 diagnostic	purposes.	 Higher	 spatial	 resolution	 of	 UHF	 also	 opens	 the	 door	 for	 in	 vivo	microscopy.		However,	in	some	cases	7	T	already	plays	a	role	in	the	clinical	environment	and	there	is	indication	that,	in	the	future,	7	T	will	be	used	more	routinely	in	specific	cases.	 For	 example,	 detection	 of	 gray	 matter	 pathologies	 in	 multiple	 sclerosis	with	 7	 T	 may	 improve	 the	 diagnostic	 possibilities.	 Also,	 subregions	 of	 the	hippocampus	are	better	accessible	with	7	T	than	3	T,	thus	enabling	detection	of	pathologies	 such	 as	 hippocampal	 sclerosis.	 High	 resolution	 imaging	 of	microadenoma	 at	 7	 T	 might	 provide	 a	 direct	 criterion	 of	 cavernous	 sinus	infiltration.	 Furthermore,	 angiograms	 of	 lenticulo-striate	 arteries	 have	 shown	differences	 between	 dementia	 patients	 and	 controls.	 In	 preoperative	 fMRI,	spatial	 accuracy	 is	 of	 utmost	 importance	 in	 order	 to	 reach	 the	 best	 possible	
		 8	
outcome.	In	a	comparison	study	between	7	T	and	3	T,	it	was	shown	that	7	T	fMRI	provided	more	accurate	information	about	the	location	of	the	tumor	in	relation	to	functionally	important	brain	areas.		It	 is	essential	 to	start	using	7	T	 in	basic	 research	and	clinical	 research	as	soon	and	 as	 widely	 as	 possible	 to	 support	 the	 development	 of	 7	 T	 into	 a	 future	valuable	tool	of	clinical	diagnostics.	
Is	 it	possible	 to	use	7	T	 for	other	 than	neuro	applications,	 such	as	 liver	 fat	
and	muscle	imaging?	What	about	spectroscopy	and	multinuclear	imaging?	UHF	has	significant	potential	in	imaging	also	other	tissues,	e.g.,	musculoskeletal	tissues.	With	a	modern	7	T	scanner	it	is	also	feasible	to	image	the	human	body,	as	many	of	the	early-stage	issues	with	7	T,	such	as	inhomogeneity	of	the	RF	field,	have	been	 solved.	 Preoperative	median	nerve	 imaging	has	been	performed,	 as	well	 as	 multiparametric	 MR	 mammography	 at	 7	 T,	 demonstrating	 that	 MR	imaging	has	potential	to	obviate	unnecessary	breast	biopsies.		In	 spectroscopy,	 7	 T	 compared	 to	 3	 T	 affords	 better	 chemical	 discrimination	(larger	 separation	 between	 the	 spectral	 peaks	 representing	 different	metabolites)	 and	higher	SNR	within	a	practicable	 imaging	 time.	With	 chemical	exchange	saturation	transfer	(CEST),	it	is	possible	to	map	glutamate,	which	has	not	been	possible	with	traditional	methods	of	spectroscopy.		Studies	have	shown	that	non-invasive	sodium	cartilage	imaging	could	be	helpful	not	 only	 for	 assessment	 of	 the	 cartilage	 status,	 but	 also	 predictive	 for	osteoarthritis.	Non-invasive	phosphorous	saturation	transfer	of	 the	 liver	at	7	T	may	replace	invasive	liver	biopsy.	Hepatic	energy	metabolism	is	of	high	interest	as	 its	alterations	are	indicative	of	 inflammatory	and	neoplastic	 liver	diseases,	a	phenomenon	that	has	been	demonstrated	in	type	2	diabetes	patients	at	3	T.			 	
		 9	
Practical	Operation	and	Procurement	Issues	
Artifacts	 and	 possible	 difficulties	 in	 7	 T?	 Solutions	 for	 minimizing	 the	
artifacts	and	distortions?	UHF	MRI	manifests	artifacts	and	imaging	challenges	that	are	more	problematic	than	at	lower	field	strengths.	Echo	planar	imaging	(EPI),	causes	image	distortion	and	 signal	 dropout	 especially	 adjacent	 to	 frontal	 sinuses	 and	 ear	 canals.	 This	problem	 scales	 with	 field	 strength.	 However,	 recent	 advances	 in	 imaging	technology	 and	 signal	 processing,	 especially	 multi-channel	 array	 coils	 and	parallel	 transmit/receive	 methods,	 can	 reduce	 the	 susceptibility	 artifacts	 to	 a	manageable	level.	Thinner	slices	reduce	artifacts,	but	at	the	same	time	increase	scan	 time.	There	are	new	methods,	 such	as	 simultaneous	multislice	 (SMS)	EPI,	which	enables	significantly	decreased	scan	times:	the	whole	brain	can	be	imaged	with	1	mm	isotropic	voxels	in	less	than	3	seconds.	Fast	sampling	also	somewhat	reduces	 physiological	 noise	 artefacts.	 Elimination	 of	 physiological	 noise	 is,	however,	 particularly	 critical	 at	 7	 T.	 Many	 important	 advances	 have	 been	recently	made	in	alleviating	the	noise	contributing	to	EPI	signal	fluctuations.		At	7	T,	the	wavelength	of	the	RF	field	required	in	measurements	is	about	12	cm.	As	the	size	of	the	head	is	~20	cm	and	the	torso	~40	cm,	the	RF	field	within	the	imaging	volume	 is	uneven	when	using	a	 single	 transmit	 channel.	 In	particular,	the	 RF	 field	 varies	 within	 the	 volume	 due	 to	 constructive	 and	 destructive	interferences	 as	 well	 as	 dielectric	 shielding,	 resulting	 in	 fluctuating	 tissue	contrast	 in	 images.	 However,	 parallel	 transmit	 strategies	 and	 new	 pulse	sequences	(such	as	MP2RAGE)	have	been	implemented	to	solve	these	problems.	
SAR	and	other	safety	considerations	when	using	7	T?	By	default,	 specific	 absorption	 rate	 (SAR)	 is	 retained	within	 safety	 limits	 in	 all	scanning	sequences	approved	by	the	manufacturer.	SAR	is	also	monitored	by	the	scanner	 software	 and	 hardware	 at	 run-time.	 In	 case	 advanced	 techniques	 are	used	that	are	not	directly	provided	by	the	scanner	vendor	and	that	might	cause	increased	SAR,	the	safety	considerations	are	carefully	evaluated.	This	is	standard	procedure	for	all	sites	operating	an	MRI	scanner	at	any	field	strengths,	not	only	at	UHF.		Ultra-high	magnetic	 fields	and	the	associated	techniques	may	cause	short-term	side-effects.	 These	 include	 dizziness	 and	 nausea,	 nystagmus	 (eye	 drifts)	 and	possibly	 phosphenes.	 Most	 participants	 do	 not	 report	 anything	 out	 of	 the	ordinary	 when	 undergoing	 a	 7	 T	 study.	 In	 some	 follow-ups,	 one	 third	 has	reported	short-term	vertigo	when	the	patient	table	was	moving	in	and/or	out	of	
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Challenges	in	data	analysis	in	comparison	to	3	T?	The	amount	of	data	produced	by	a	7	T	scanner	 is	often	underestimated.	A	7	T	site	 needs	 highly	 qualified	 experts	 for	 dealing	 with	 the	 data	 and	 analyses.	Advanced	 techniques	 in	 the	 acquisition	 also	 require	 sophisticated	 processing	and	 analysis	 methods.	 One	 detail	 of	 major	 practical	 importance	 is	 that	 data	smoothing	should	no	longer	be	used	(as	opposed	to	the	common	approach	at	3	T).	 Localization	 information	 is	 lost	 in	 smoothing	 and,	 because	 the	 increase	 in	SNR	 is	considerable,	unsmoothed	data	 is	adequate	 to	reveal	significant	cortical	activity.	 Smoothing	 introduces	 false	 positives	 and	 makes	 it	 difficult	 to	distinguish	 activations	 on	 different	 sides	 of	 sulci,	 thus	 leading	 to	 vague	 and	misleading	associations	of	functional	activity	and	neural	substrates.		Single-subject	analysis	before	averaging	is	an	essential	step	in	data	analysis.	For	the	subsequent	group-level	analysis,	improved	methods	of	normalization	should	be	used	as	 the	 spatial	 resolution	 is	dramatically	 enhanced	 in	7	T	 imaging.	The	exquisite	 spatial	 resolution	 also	 allows	 linkage	 to	 the	myeloarchitecture	based	atlases.	
How	will	patient	flow	and	imaging	time	be	organized	if	7	T	is	to	be	installed	
in	Aalto	University,	Otaniemi	campus?	The	 premises	 will	 be	 suitable	 for	 clinical	 research	 (at	 least	 for	 outpatients).	Given	the	interest	and	prospective	users	and	applications,	specific	arrangements	can	 be	 implemented	 to	 also	 secure	 a	 patient	 flow.	 In	 the	 first	 stages	 of	 UHF	imaging	 in	Finland,	most	 studies	will	 likely	be	done	on	healthy	volunteers	and	patients	who	do	not	require	hospital	environment.	The	technologically	oriented	domain	 at	 Aalto	 University	 will	 strongly	 support	 the	 development	 of	 the	 7	 T	scanner	and	 its	use	also	 for	precision	measurements	 in	both	basic	 and	 clinical	research.		The	7	T	will	be	an	open-access	facility,	with	imaging	time	distributed	among	the	user	groups	via	a	web-based	reservation	system,	 taking	care	of	equal	scanning	opportunities	and	ensuring	efficient	use	of	the	device.	In	specific	cases	(visitors	from	abroad,	urgent	patient/subject	groups,	nature	of	the	study)	a	group	can	be	given	 privilege	 to	 reservations	 for	 a	 limited	 time.	 This	 policy	 has	 been	successfully	 in	 use	 in	 the	 ANI	 infrastructure	 for	 several	 years.	 In	 case	 the	demand	 would	 surpass	 the	 supply,	 a	 joint	 expert	 board	 between	 the	 user	institutions	will	prioritize	the	use.	
		 12	
Status	of	vendors?	Previously,	the	UHF	MRI	scanners	have	been	research	instruments	more	or	less	custom-built	 to	 the	 order.	 We	 have	 started	 inquiries	 with	 all	 major	 vendors	(Siemens	Healthcare,	GE	Healthcare,	and	Philips	Healthcare),	in	order	to	further	explore	 their	 current	 UHF	 systems	 and	 solutions.	 Siemens	 Healthcare	 has	recently	 launched	a	7	T	product,	MAGNETOM	Terra1),	and	 is	pursuing	the	FDA	and	CE	approvals	 for	 future	clinical	use.	To	our	knowledge,	GE	Healthcare	and	Philips	Healthcare	are	also	committed	to	their	7	T	programs.	
Research	 agreements	 with	 vendors	 (e.g.,	 sequence	 development)	 if	 other	
than	Aalto	or	FIFI-affiliated	users	need	to	do	some	development?	The	owner	organization	(Aalto	University)	will	make	a	research	agreement	with	the	winner	of	the	procurement	process	among	vendors	(this	will	be	a	condition	in	the	competitive	bidding).	If	possible	and	agreed	by	the	vendor,	an	option	will	be	 included	 for	other	users	 to	 take	part	 in,	e.g.,	 sequence	development.	This	 is	likely	the	case,	but	if	not,	ANI	will	offer	research	collaboration	and	its	knowhow	in	sharing	the	advanced	methods	with	the	larger	community	as	well.	
Procurement	process	and	cost	The	owner	organization	(Aalto	University)	will	handle	the	procurement	process	and	competitive	bidding	of	 the	future	7	T	system	provided	that	 funding	can	be	secured.	Our	current	estimate	for	the	price	of	a	7	T	system	is	7	000	000	€.	The	required	 stimulus	 systems,	 physiological	 measurement	 devices	 and	 related	computer	 systems	 needed	 in	 basic	 and	 clinical	 research	 sum	 up	 to	approximately	 500	 000	 €.	 With	 additional	 costs	 in,	 e.g.,	 implementing	 a	possibility	for	handling	a	patient	flow,	the	total	cost	of	the	project	is	expected	to	be	 close	 to	 8	 000	 000	 €.	 This	 estimate	 is	 made	 by	 the	 institute	 and	 is	 not	committed	 to	 by	 any	 of	 the	 vendors.	 The	 final	 cost	 depends	 on	 the	 particular	configuration	of	the	system	and	may	be	subject	to	changes.		The	 annual	 expenses	 after	 purchase	 include	 rental	 cost	 of	 approximately	 100	000	€/year	(400	m2),	service	contract	for	the	scanner	200	000	€/year	(our	best	estimate	at	this	point),	and	a	minimum	of	two	MR	physicists,	together	about	200	000	€/year	depending	on	their	seniority.	Thus,	the	basic	operation	and	upkeep	will	cost	approximately	500	000	€/year,	which	would	be	covered	by	user	fees.	During	and	right	after	the	startup	phase	(2	years	after	installation),	when	most	groups	are	still	learning	to	use	a	7	T	scanner,	the	total	use	will	likely	not	yet	fully	cover	the	running	costs.	However,	2–3	years	after	installation,	the	7	T	system	is																																																									1	www.healthcare.siemens.com/magnetic-resonance-imaging/7t-mri-scanner/magnetom-terra	
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anticipated	to	have	a	well-established	user	base	in	Finland,	and	the	upkeep	will	be	covered	mainly	by	user	fees.			The	high	cost	of	the	7	T	project	necessitates	a	broad	support	from	all	universities	and	institutions	in	Finland	that	are	interested	in	using	UHF	human	devices.	Such	support	 may	 include	 sharing	 of	 some	 of	 the	 initial	 costs.	 Most	 importantly,	strong	financial	and	scientific	support	from	the	top	officials	of	Aalto	University	is	an	absolute	prerequisite	for	a	successful	outcome	of	this	project.	
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Venue:		 	 Aalto	Design	Factory,	The	Stage		 	 Betonimiehenkuja	5C,	Espoo	(Otaniemi)		
Lunches:		 Restaurant	Antell	Calori	(code:	“7T”)		 	 		
Thursday,	October	8		11:30	–	12:00	 	 On-site	registration	12:00	–	12:30	 	 Opening	ceremony	12:30	–	14:10	 	 Scientific	session		 	 	 	 Turner:	How	7T	MRI	can	transform	neuroscience	Formisano:	High-resolution	investigations	of	the	human	
auditory	system	with	functional	MRI	at	7	Tesla	(and	more)	14:10	–	14:40	 	 Coffee	break	14:40	–	16:20	 	 Scientific	session	Polimeni:	High	spatial	and	temporal	resolution	fMRI	at	
Ultra-high	fields:	prospects	for	new	neuroscience	Kettunen:	When	ultra-high	magnetic	field	is	not	enough:	
Hyperpolarised	13C	MRI	and	its	applications	16:20	–	16:30	 	 Break	16:30	–	18:10	 	 Scientific	session	Kauppinen:	Haemodynamic	MRI	of	the	brain	at	7T	Bianciardi:	Echo-planar-imaging	of	human	brain	function,	
physiology,	and	structure	at	7	Tesla:	challenges	and	opportunities	18:10	–	onwards	 	 Cocktail	reception			
Friday,	October	9		08:30	–	10:10	 	 Scientific	session		 	 	 	 Trattnig:	The	Forefront	of	Clinical	MRI	Studies	at	Ultra	High	Fields	Clare:	Translational	and	clinical	research	with	ultra-high	field	MRI	10:10	–	10:40	 	 Coffee	break	10:40	–	11:30	 	 Scientific	session	Ugurbil:	Imaging	Function	and	Connectivity	in	the	Human	Brain	with	
High	Magnetic	Fields:	spanning	scales	from	cortical	columns	to	whole	
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A workshop “Ultra-High Field MRI: 
Transition to Human 7 T in Finland” was 
organized at Aalto University on October 
8–9, 2015. The organizers included Aalto 
University School of Science, Finnish 
Infrastructures for Functional Imaging 
(FIFI), Aalto NeuroImaging (ANI), Aalto 
Brain Centre (ABC), and Department of 
Neuroscience and Biomedical Engineering 
(NBE). The purpose of the workshop was to 
demonstrate scientiﬁc achievements and 
possibilities enabled by ultra-high ﬁeld 
(UHF) magnetic resonance imaging (MRI). 
The meeting brought together a group of 
top-level scientists for two days to give 
presentations and immerse in discussions. 
This memorandum not only documents the 
meeting but also paves the way for making 
the ﬁrst human 7 T scanner operational in 
Finland in the near future. 
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